We are live on
!
Find out more
Ginkgo Bioworks
DNA
DNA
260 hedge funds and large institutions have $1.93B invested in Ginkgo Bioworks in 2022 Q2 according to their latest regulatory filings, with 101 funds opening new positions, 78 increasing their positions, 40 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
261% more first-time investments, than exits
New positions opened: 101 | Existing positions closed: 28
95% more repeat investments, than reductions
Existing positions increased: 78 | Existing positions reduced: 40
37% more funds holding
Funds holding: 190 → 260 (+70)
33% more call options, than puts
Call options by funds: $14.3M | Put options by funds: $10.8M
0.53% more ownership
Funds ownership: 1.27% → 1.8% (+0.53%)
28% less capital invested
Capital invested by funds: $2.68B → $1.93B (-$746M)
33% less funds holding in top 10
Funds holding in top 10: 12 → 8 (-4)
Holders
260
Holders Change
+70
Holders Change %
+36.84%
% of All Funds
4.38%
Holding in Top 10
8
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-33.33%
% of All Funds
0.13%
New
101
Increased
78
Reduced
40
Closed
28
Calls
$14.3M
Puts
$10.8M
Net Calls
+$3.55M
Net Calls Change
+$13.6M
Top Buyers
Top Sellers
| 1 |
SIG
Senator Investment Group
New York
|
-$106M |
| 2 |
Viking Global Investors
Stamford,
Connecticut
|
-$73.1M |
| 3 |
GA
General Atlantic
New York
|
-$65.2M |
| 4 |
HF
HRT Financial
New York
|
-$30.6M |
| 5 |
CC
Casdin Capital
New York
|
-$16.9M |
